0001415889-24-001830.txt : 20240125
0001415889-24-001830.hdr.sgml : 20240125
20240125200032
ACCESSION NUMBER: 0001415889-24-001830
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240123
FILED AS OF DATE: 20240125
DATE AS OF CHANGE: 20240125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanderling Venture Partners VI Co Investment Fund LP
CENTRAL INDEX KEY: 0001306695
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 24563794
BUSINESS ADDRESS:
STREET 1: 1300 S EL CAMINO REAL SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: 650-401-2000
MAIL ADDRESS:
STREET 1: 1300 S EL CAMINO REAL SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanderling Venture Partners VI LP
CENTRAL INDEX KEY: 0001306717
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 24563795
BUSINESS ADDRESS:
STREET 1: 1300 S EL CAMINO REAL SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: 650-401-2000
MAIL ADDRESS:
STREET 1: 1300 S EL CAMINO REAL SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanderling Ventures Management VI
CENTRAL INDEX KEY: 0001429588
ORGANIZATION NAME:
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 24563793
BUSINESS ADDRESS:
STREET 1: 1300 S EL CAMINO REAL SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: (650) 401-2000
MAIL ADDRESS:
STREET 1: 1300 S EL CAMINO REAL SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanderling Ventures VII (Canada), L.P.
CENTRAL INDEX KEY: 0001993660
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 24563790
BUSINESS ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL, SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: 650-401-2000
MAIL ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL, SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanderling Ventures VII, L.P.
CENTRAL INDEX KEY: 0001565862
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 24563792
BUSINESS ADDRESS:
STREET 1: 400 SOUTH EL CAMINO REAL, SUITE 1200
CITY: SAN MATEO
STATE: CA
ZIP: 94402-1708
BUSINESS PHONE: 650-401-2011
MAIL ADDRESS:
STREET 1: 400 SOUTH EL CAMINO REAL, SUITE 1200
CITY: SAN MATEO
STATE: CA
ZIP: 94402-1708
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanderling Ventures VII Annex Fund, L.P.
CENTRAL INDEX KEY: 0001678656
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 24563791
BUSINESS ADDRESS:
STREET 1: 400 SOUTH EL CAMINO REAL, SUITE 1200
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: (650) 401-2011
MAIL ADDRESS:
STREET 1: 400 SOUTH EL CAMINO REAL, SUITE 1200
CITY: SAN MATEO
STATE: CA
ZIP: 94402
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sanderling Ventures Management VII
CENTRAL INDEX KEY: 0001993457
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39538
FILM NUMBER: 24563789
BUSINESS ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL
STREET 2: SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: 650-401-2000
MAIL ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL
STREET 2: SUITE 203
CITY: SAN MATEO
STATE: CA
ZIP: 94402
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CalciMedica, Inc.
CENTRAL INDEX KEY: 0001534133
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 452120079
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: 858-952-5500
MAIL ADDRESS:
STREET 1: 505 COAST BOULEVARD SOUTH
STREET 2: SUITE 307
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: CalciMedica, Inc. /DE/
DATE OF NAME CHANGE: 20230322
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG VISION, INC.
DATE OF NAME CHANGE: 20170717
FORMER COMPANY:
FORMER CONFORMED NAME: GRAYBUG, Inc.
DATE OF NAME CHANGE: 20150303
4
1
form4-01252024_080106.xml
X0508
4
2024-01-23
0001534133
CalciMedica, Inc.
CALC
0001306717
Sanderling Venture Partners VI LP
1300 S. EL CAMINO REAL SUITE 203
SAN MATEO
CA
94402
false
false
true
false
0001306695
Sanderling Venture Partners VI Co Investment Fund LP
1300 S EL CAMINO REAL
SUITE 203
SAN MATEO
CA
94402
0
0
1
0
0001429588
Sanderling Ventures Management VI
1300 S EL CAMINO REAL
SUITE 203
SAN MATEO
CA
94402
0
0
1
0
0001565862
Sanderling Ventures VII, L.P.
1300 S. EL CAMINO REAL
SUITE 203
SAN MATEO
CA
94402
0
0
1
0
0001678656
Sanderling Ventures VII Annex Fund, L.P.
1300 S EL CAMINO REAL
SUITE 203
SAN MATEO
CA
94402
0
0
1
0
0001993660
Sanderling Ventures VII (Canada), L.P.
1300 S. EL CAMINO REAL SUITE 203
SAN MATEO
CA
94402
0
0
1
0
0001993457
Sanderling Ventures Management VII
1300 S. EL CAMINO REAL SUITE 203
SAN MATEO
CA
94402
0
0
1
0
0
Common Stock
2024-01-23
4
P
0
243356
3.702
A
946744
D
Common Stock
2024-01-23
4
P
0
144676
3.702
A
727433
I
By Sanderling Venture Partners VI Co-Investment Fund, L.P.
Common Stock
2024-01-23
4
P
0
194472
3.702
A
435148
I
By Sanderling Ventures VII, L.P.
Common Stock
2024-01-23
4
P
0
51032
3.702
A
114260
I
By Sanderling Ventures VII (Canada), L.P.
Common Stock
2024-01-23
4
P
0
13184
3.702
A
27609
I
By Sanderling Ventures VII Annex Fund, L.P.
Common Stock
2024-01-23
4
P
0
3920
3.702
A
21602
I
By Sanderling Ventures Management VI
Common Stock
2024-01-23
4
P
0
28744
3.702
A
30292
I
By Sanderling Ventures Management VII
Warrant
5.36
2024-01-23
4
P
0
121678
0.125
A
2024-01-23
2024-12-31
Common Stock
121678
121678
D
Warrant
7.15
2024-01-23
4
P
0
121678
0.125
A
2024-01-23
2026-12-31
Common Stock
121678
121678
D
Warrant
5.36
2024-01-23
4
P
0
72338
0.125
A
2024-01-23
2024-12-31
Common Stock
72338
72338
I
By Sanderling Venture Partners VI Co-Investment Fund, L.P.
Warrant
7.15
2024-01-23
4
P
0
72338
0.125
A
2024-01-23
2026-12-31
Common Stock
72338
72338
I
By Sanderling Venture Partners VI Co-Investment Fund, L.P.
Warrant
5.36
2024-01-23
4
P
0
97236
0.125
A
2024-01-23
2024-12-31
Common Stock
97236
97236
I
By Sanderling Ventures VII, L.P.
Warrant
7.15
2024-01-23
4
P
0
97236
0.125
A
2024-01-23
2026-12-31
Common Stock
97236
97236
I
By Sanderling Ventures VII, L.P.
Warrant
5.36
2024-01-23
4
P
0
25516
0.125
A
2024-01-23
2024-12-31
Common Stock
25516
25516
I
By Sanderling Ventures VII (Canada), L.P.
Warrant
7.15
2024-01-23
4
P
0
25516
0.125
A
2024-01-23
2026-12-31
Common Stock
25516
25516
I
By Sanderling Ventures VII (Canada), L.P.
Warrant
5.36
2024-01-23
4
P
0
6592
0.125
A
2024-01-23
2024-12-31
Common Stock
6592
6592
I
By Sanderling Ventures VII Annex Fund, L.P.
Warrant
7.15
2024-01-23
4
P
0
6592
0.125
A
2024-01-23
2026-12-31
Common Stock
6592
6592
I
By Sanderling Ventures VII Annex Fund, L.P.
Warrant
5.36
2024-01-23
4
P
0
1960
0.125
A
2024-01-23
2024-12-31
Common Stock
1960
1960
I
By Sanderling Ventures Management VI
Warrant
7.15
2024-01-23
4
P
0
1960
0.125
A
2024-01-23
2026-12-31
Common Stock
1960
1960
I
By Sanderling Ventures Management VI
Warrant
5.36
2024-01-23
4
P
0
14372
0.125
A
2024-01-23
2024-12-31
Common Stock
14372
14372
I
By Sanderling Ventures Management VII
Warrant
7.15
2024-01-23
4
P
0
14372
0.125
A
2024-01-23
2026-12-31
Common Stock
14372
14372
I
By Sanderling Ventures Management VII
The securities were acquired from the Issuer pursuant to a Securities Purchase Agreement dated January 19, 2024, with a closing date of January 23, 2024. The Securities Purchase Agreement and the issuance of the securities thereunder was approved by an independent committee of the Issuer's Board of Directors.
The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2024, and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's Phase 2b clinical trial in patients with acute pancreatitis but not thereafter.
The warrant may be exercised on or after January 23, 2024, and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on December 31, 2026 and (ii) thirty (30) days following the Issuer's public disclosure of topline results from the Issuer's planned Phase 2 clinical trial in patients with acute kidney injury but not thereafter.
/s/ Sanderling Venture Partners VI, L.P., By: /s/ Timothy C. Mills, Managing Director of Middleton, McNeil & Mills Associates VI, L.P., its General Partner
2024-01-25
/s/ Sanderling Venture Partners VI Co-Investment Fund, L.P., By: /s/ Timothy C. Mills, Managing Director of Middleton, McNeil & Mills Associates VI, LLC, its General Partner
2024-01-25
/s/ Sanderling Ventures VII (Canada), L.P., By: /s/ D. Michael Dixon, President of Sanderling Ventures VII (Canada) GP Inc., General Partner of Sanderling Ventures VII (Canada) G.P., L.P, its General Partner
2024-01-25
/s/ Sanderling Ventures VII, L.P. , By: /s/ Timothy C. Mills, Managing Director of M4 Partners VII, LLC, its General Partner
2024-01-25
/s/ Sanderling Ventures VII Annex Fund, L.P., By: /s/ Timothy C. Mills, Managing Director of M4 Partners VII Annex, LLC, its General Partner
2024-01-25
/s/ Sanderling Ventures Management VII, By: /s/ Timothy C. Mills, Owner
2024-01-25
/s/ Sanderling Ventures Management VI, By: /s/ Timothy C. Mills, Owner
2024-01-25